{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:10Z","timestamp":1791037030824,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10689-011-9498-y","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T05:14:37Z","timestamp":1323666877000},"page":"181-188","source":"Crossref","is-referenced-by-count":18,"title":["Validation of three BRCA1\/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families"],"prefix":"10.1007","volume":"11","author":[{"given":"S. M.","family":"Schneegans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Emons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shoukier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"issue":"2","key":"9498_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9498_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jech.2008.083774","volume":"66","author":"K Zbuk","year":"2012","unstructured":"Zbuk K, Anand SS (2012) Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries. J Epidemiol Community Health 66(1):1\u20137","journal-title":"J Epidemiol Community Health"},{"key":"9498_CR3","doi-asserted-by":"crossref","first-page":"c3620","DOI":"10.1136\/bmj.c3620","volume":"341","author":"P Autier","year":"2010","unstructured":"Autier P, Boniol M, La Vecchia C et al (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341:c3620","journal-title":"BMJ"},{"issue":"8","key":"9498_CR4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, EM Ward (2010) Global patterns of cancer incidence, mortality rates, trends. Cancer Epidemiol Biomarkers Prev 19(8):1893\u20131907","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9498_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity, penetrance analysis of the BRCA1, BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"12","key":"9498_CR6","first-page":"1691","volume":"54","author":"JC Carroll","year":"2008","unstructured":"Carroll JC, Cremin C, Allanson J et al (2008) Hereditary breast and ovarian cancers. Can Fam Physician 54(12):1691\u20131692","journal-title":"Can Fam Physician"},{"issue":"5","key":"9498_CR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C et al (2010) Germline mutations in breast, ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410\u2013414","journal-title":"Nat Genet"},{"key":"9498_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-12-9","volume":"12","author":"V Stegel","year":"2011","unstructured":"Stegel V, Krajc M, Zgajnar J et al (2011) The occurrence of germline BRCA1, BRCA2 sequence alterations in Slovenian population. BMC Med Genet 12:9","journal-title":"BMC Med Genet"},{"key":"9498_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12687-011-0042-4","volume":"2","author":"D Gadzicki","year":"2011","unstructured":"Gadzicki D, Evans DG, Harris H et al (2011) Genetic testing for familial\/hereditary breast cancer\u2014comparison of guidelines and recommendations from the UK, France, The Netherlands and Germany. J Community Genet 2:53\u201369","journal-title":"J Community Genet"},{"issue":"10","key":"9498_CR10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102(10):680\u2013691","journal-title":"J Natl Cancer Inst"},{"key":"9498_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000091305","volume":"1","author":"B Kuschel","year":"2006","unstructured":"Kuschel B, Hauenstein E, Kiechle M, Meindl A (2006) Hereditary breast and ovarian cancer\u2014current clinical guidelines in Germany. Breast Care 1:8\u201314","journal-title":"Breast Care"},{"key":"9498_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2350-8-13","volume":"8","author":"H Katki","year":"2007","unstructured":"Katki H (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13","journal-title":"BMC Med Genet"},{"issue":"4","key":"9498_CR13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-08-1090","volume":"18","author":"AW Kurian","year":"2009","unstructured":"Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial\/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18(4):1084\u20131091","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9498_CR14","first-page":"A1372","volume":"99","author":"R Schmutzler","year":"2002","unstructured":"Schmutzler R, Beckmann M, Kiechle M (2002) Prevention: hereditary breast and ovarian cancer. Dtsch Arztebl 99:A1372\u2013A1378","journal-title":"Dtsch Arztebl"},{"key":"9498_CR15","unstructured":"Kreienberg R, Kopp I, Albert U et al. (2008) Interdisziplinare S3-leitlinie fur die diagnostik, therapie und nachsorge des mammakarzinoms. Munich, W. Zuckschwerdt Verlag GmbH"},{"key":"9498_CR16","doi-asserted-by":"crossref","unstructured":"Bayraktar S, Elsayegh N, Gutierrez Barrera AM et al. (2011) Predictive factors for BRCA1\/BRCA2 mutations in women with ductal carcinoma in situ. Cancer","DOI":"10.1002\/cncr.26428"},{"issue":"18","key":"9498_CR17","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1200\/JCO.2002.02.130","volume":"20","author":"C Cremin","year":"2002","unstructured":"Cremin C, Wong N, Buzaglo K, Paradis AJ, Foulkes W (2002) Nonovarian pelvic cancers in BRCA1\/2 mutation carriers and the BRCAPRO statistical model. J Clin Oncol 20(18):3936","journal-title":"J Clin Oncol"},{"issue":"3","key":"9498_CR18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837\u2013845","journal-title":"Biometrics"},{"issue":"7","key":"9498_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad, the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431","journal-title":"J Med Genet"},{"issue":"29","key":"9498_CR20","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1200\/JCO.2008.16.8310","volume":"26","author":"AW Kurian","year":"2008","unstructured":"Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1\/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752\u20134758","journal-title":"J Clin Oncol"},{"issue":"4","key":"9498_CR21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10689-007-9150-z","volume":"6","author":"NM Lindor","year":"2007","unstructured":"Lindor NM, Lindor RA, Apicella C et al (2007) Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models. Fam Cancer 6(4):473\u2013482","journal-title":"Fam Cancer"},{"issue":"7","key":"9498_CR22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/sj.bjc.6603358","volume":"95","author":"HH Kang","year":"2006","unstructured":"Kang HH, Williams R, Leary J, Ringland C, Kirk J, Ward R (2006) Evaluation of models to predict BRCA germline mutations. Br J Cancer 95(7):914\u2013920","journal-title":"Br J Cancer"},{"key":"9498_CR23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-9-116","volume":"9","author":"SM Panchal","year":"2008","unstructured":"Panchal SM, Ennis M, Canon S, Bordeleau LJ (2008) Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet 9:116","journal-title":"BMC Med Genet"},{"issue":"3","key":"9498_CR24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/CEJ.0b013e32801023b3","volume":"16","author":"PA Fasching","year":"2007","unstructured":"Fasching PA, Bani MR, Nestle-Kramling C et al (2007) Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16(3):216\u2013224","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"9498_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2007.02.013","volume":"57","author":"MW Beckmann","year":"2007","unstructured":"Beckmann MW, Bani MR, Fasching PA, Strick R, Lux MP (2007) Risk and risk assessment for breast cancer: molecular and clinical aspects. Maturitas 57(1):56\u201360","journal-title":"Maturitas"},{"key":"9498_CR26","doi-asserted-by":"crossref","unstructured":"Kast K, Schmutzler RK, Distler W et al. (2009) Prevalence rates of pathogenic mutations in the BRCA1 and BRCA2 genes in families with different disease histories: results from the German consortium for hereditary breast and ovarian cancer. Cancer Res 69(24):731S-S","DOI":"10.1158\/0008-5472.SABCS-09-4073"},{"issue":"3","key":"9498_CR27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/gyno.1998.5270","volume":"72","author":"J Backe","year":"1999","unstructured":"Backe J, Hofferbert S, Skawran B et al (1999) Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol 72(3):402\u2013406","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9498_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","volume":"14","author":"BB Roa","year":"1996","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1, BRCA2. Nat Genet 14(2):185\u2013187","journal-title":"Nat Genet"},{"issue":"3","key":"9498_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12038-009-0048-9","volume":"34","author":"K Vaidyanathan","year":"2009","unstructured":"Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K (2009) BRCA1, BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations, high-frequency occurrence of 185delAG mutation. J Biosci 34(3):415\u2013422","journal-title":"J Biosci"},{"issue":"3","key":"9498_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cncr.11533","volume":"98","author":"LG Mullineaux","year":"2003","unstructured":"Mullineaux LG, Castellano TM, Shaw J et al (2003) Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98(3):597\u2013602","journal-title":"Cancer"},{"issue":"7","key":"9498_CR31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ejhg.2010.29","volume":"18","author":"I Zanna","year":"2010","unstructured":"Zanna I, Rizzolo P, Sera F et al (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling, clinical management of male breast cancer cases. Eur J Hum Genet 18(7):856\u2013858","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"9498_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, van Rensburg EJ (2011) Large genomic rearrangements of the BRCA1, BRCA2 genes: review of the literature, report of a novel BRCA1 mutation. Breast Cancer Res Treat 125(2):325\u2013349","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"9498_CR33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/humu.20723","volume":"29","author":"S Engert","year":"2008","unstructured":"Engert S, Wappenschmidt B, Betz B et al (2008) MLPAscreening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, occurrence in single early-onset cases. Hum Mutat 29(7):948\u2013958","journal-title":"Hum Mutat"},{"issue":"6","key":"9498_CR34","doi-asserted-by":"crossref","first-page":"vi86","DOI":"10.1093\/annonc\/mdm233","volume":"18","author":"S Veschi","year":"2007","unstructured":"Veschi S, Aceto G, Scioletti AP et al (2007) High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. Ann Oncol 18(6):vi86\u2013vi92","journal-title":"Ann Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10689-011-9498-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T15:52:23Z","timestamp":1561045943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-011-9498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9498"],"URL":"https:\/\/doi.org\/10.1007\/s10689-011-9498-y","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}